Ionis Pharmaceuticals (IONS) Earnings Analysis

Ionis Pharmaceuticals (IONS) next reports earnings on 2026-07-29, consensus EPS -1.09141 USD. Last quarter (2026-02-25) it missed with EPS -1.41 USD vs -1.23667 USD est (-14%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E -27.14.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does IONS next report earnings?

Next earnings date2026-07-29
Consensus EPS estimate-1.09141 USD
Revenue estimate0.19B

IONS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-25-1.41 USD-1.23667 USD-14%Miss
2025-10-29-0.61 USD-1.15 USD+47%Beat
2025-07-300.86 USD0.27 USD+218.5%Beat
2025-04-30-0.75 USD-1.11 USD+32.4%Beat
2025-02-19-0.66 USD-1.09 USD+39.4%Beat
2024-08-01-0.45 USD-0.92 USD+51.1%Beat

Beat rate: 5/6 (83%) over reported quarters with consensus data.

IONS valuation and analyst view

Trailing P/E-27.14
Trailing EPS-1.9808 USD
Price / book18.12
Dividend yield0.00%
Market cap8.64B
Analyst consensusBuy (20 buy / 13 hold / 0 sell)
Avg price target99.08 USD

Related research pages

Frequently asked questions

When is Ionis Pharmaceuticals (IONS)'s next earnings date?

Ionis Pharmaceuticals is next scheduled to report on 2026-07-29, with a consensus EPS estimate of -1.09141 USD and revenue estimate of 0.19B.

Did IONS beat earnings last quarter?

In its 2026-02-25 report, IONS posted EPS of -1.41 USD versus a -1.23667 USD estimate — a miss of 14%.

What is IONS's earnings track record?

Over the last 6 reported quarters with consensus data, IONS beat estimates 5 times (83%).

What is IONS's current P/E ratio and EPS?

IONS trades at a trailing P/E of -27.14 on trailing EPS of -1.9808035226900542 USD.

What do analysts rate IONS?

Analyst consensus is "Buy" across 33 ratings (1 strong buy, 19 buy, 13 hold, 0 sell, 0 strong sell). Average 12-month price target: 99.08 USD.